Lung Health

Driving Advances in Lung Cancer Detection

Lung cancer is the leading cause of cancer death in the United States, accounting for about 1 in 5 of all cancer deaths. Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined. However, Riverain’s ClearRead technology is leveling the playing field in early lung cancer detection, eliminating the barriers that often stand in the way of clear and accurate reads while reducing radiologists’ time that’s typically spent to inspect and evaluate pulmonary nodules.

Why is Early Detection Important?

An estimated 238,000 new cases of lung cancer will be diagnosed, and 127,000 deaths will occur this year.
Nodule search is burdensome with 95% ultimately having no findings or benign findings.
The approximate length a diagnosis is delayed when missed the first time is 200 days.
31% of radiologists are involved in a lawsuit during their career with diagnostic error as the most common cause.
Missed lung cancer is the second most frequent cause of malpractice (following breast cancer).

The Riverain Solution

The American Cancer Society cites that the number of deaths from lung cancer continues to drop, due to fewer people smoking and advances in early detection and treatment. Still, according to the NLST, half of all lung cancers are found on the follow-up scan, not the original scan. This means that early diagnosis is often the key for future success.

ClearRead™ Chest is a comprehensive AI suite for X-ray and CT that improves the early detection of pulmonary nodules. Both ClearRead Xray and ClearRead CT give radiologists and doctors the tools and information they need to make informed decisions for better patient results. Our AI-driven platform is built upon three layers of analysis.

Suppress

Our unique and patented technology removes bones and machine noise from CTs and X-rays for an unimpaired view of the chest.

Detect

ClearRead automatically detects, segments, and measures regions of interest to easily and identify possible pulmonary nodules.

Compare

By comparing nodule sizes from a current exam to prior exams, ClearRead provides an invaluable measurement tool to detect emerging nodules.

Early Detection

Makes a Difference One Life at a Time

Dr. Ehab Youssef, a Cardio-Thoracic Imaging Radiologist for Regional Medical Imaging in Michigan explains how ClearRead’s early detection capabilities saved a patient who may have otherwise gone untreated.

Lung Cancer Resources

For a Clearer Understanding

Get up to speed on lung cancer data, the latest detection methods and how to build a community program at your own healthcare organization.

Use Our Resources

Contact us

Thank you for your interest in Riverain Technologies. Whether you'd like to arrange a demo, create a service request, or simply share a question or concern with our team, please contact us. We're ready to help.